Zane Venture Fund

Shila Nieves Burney leads investment decisions as Managing Partner. She brings 20 years of experience from national health organizations, including the American Cancer Society and Black Women's Health Imperative. The team also includes Sig Mosley, a recognized angel investor in the Southeast.

The firm uses its proprietary Zane Access accelerator platform to identify founders with clinical or patient experience who are building B2B health platforms. This structure allows Zane to engage with companies before they reach broad market awareness, particularly in the Southeast where venture competition is lower.

Zane invests at the earliest stages, from pre-revenue to $500,000 ARR. The firm's numbers indicate that for every dollar it invested from Fund I, $24 followed from other investors, suggesting it often takes an initial position that is subsequently built upon by larger strategic and financial backers.

Zane does not invest in direct-to-consumer health apps or wellness products without an enterprise B2B component. The firm focuses on platforms that serve payers, employers, and health systems, and explicitly targets the shift from reactive treatment to proactive prevention, avoiding companies that replicate existing fee-for-service models.

Zane Access is the firm's proprietary accelerator platform, distinct from the venture fund but operating as its primary sourcing engine. It finds and develops founders with lived health experience, creating a pipeline of companies that the fund can then evaluate for investment.